The world cancer count for 2002: about 10.9 million new cases and about 24.6 million people living within three years of a cancer diagnosis, with lung, breast and colorectal cancers the three most common.
Parkin, Bray, Ferlay and Pisani presented the GLOBOCAN 2002 estimates of incidence, mortality and prevalence for 26 cancers worldwide. They estimated 10.9 million new cases, 6.7 million deaths and 24.6 million people alive within three years of diagnosis. Lung cancer was the most common cancer and the leading cause of cancer death, followed by breast and colorectal cancers for incidence, and the paper documented the contrasting patterns of developed and developing regions, including the large burden of stomach, liver and cervical cancers in the latter.
The first of the modern GLOBOCAN summaries in CA, it set the template that Jemal, Torre, Bray and Sung later followed and provides the 2002 baseline for tracking how the global burden has grown and shifted.
Shares Jemal 2011: Global cancer statistics (GLOBOCAN 2008), Freddie Bray, Incidence versus prevalence, Mortality.
Shares Freddie Bray, Incidence versus prevalence, Mortality, International Agency for Research on Cancer (IARC / WHO).
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO).
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO).
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO).
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance, Non-small-cell lung cancer.
Shares Freddie Bray, International Agency for Research on Cancer (IARC / WHO), HR-positive / HER2-negative breast cancer, Colorectal cancer.
Shares Incidence versus prevalence, Mortality, Cancer registries and population surveillance, Colorectal cancer.